Baroness Natalie Bennett to Join Global Scientists in Belfast for Major Summit on Antimicrobial Resistance

Baroness Natalie Bennett joins scientists in Belfast for the Microbiology Society’s 2026 conference to tackle the global rise of antimicrobial resistance.

By: AXL Media

Published: Apr 13, 2026, 7:54 AM EDT

Source: Information for this report was sourced from EurekAlert

Belfast Convenes International Experts on Pathogen Evolution

The Microbiology Society has selected Belfast to host its 2026 Annual Conference, marking the city as a focal point for one of Europe’s most significant scientific gatherings. This summit brings together a diverse array of global researchers to present the latest findings in microbial science and forge collaborative solutions to worldwide health crises. Central to the event is the challenge of antimicrobial resistance, a phenomenon where microbes evolve to withstand medical treatments, thereby complicating the management of infectious diseases in both human and animal populations.

Political Advocacy in the Fight Against Superbugs

Baroness Natalie Bennett, a member of the House of Lords and former leader of the Green Party, is scheduled to participate in high level discussions regarding the spread of superbugs. Her involvement underscores a growing movement to integrate scientific research with mainstream political policy. According to Baroness Bennett, while public awareness of viral threats like Covid and avian influenza has increased, the long term danger of pathogens becoming immune to existing drugs, including those for tuberculosis and typhoid, requires more urgent legislative attention.

Environmental Drivers and Consumer Product Risks

A primary focus of the conference will be the examination of how environmental factors contribute to the acceleration of drug resistance. Baroness Bennett highlighted the risks associated with the widespread use of biocides in common consumer goods, such as mouthwash, handwash, and period products. She argues that the profit driven inclusion of these chemicals creates unnecessary evolutionary pressure on microbes, effectively training them to survive medical interventions. This perspective shifts the conversation from clinical settings to the broader environmental and commercial landscape.